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The Papanicolaou Society of Cytopathology has developed a set
of guidelines for pancreatobiliary cytology including indications
for endoscopic ultrasound guided fine-needle aspiration biopsy,
techniques of the endoscopic retrograde cholangiopancreatogra-
phy, terminology and nomenclature of pancreatobiliary disease,
ancillary testing, and postbiopsy management. All documents
are based on the expertise of the authors, a review of the litera-
ture, discussions of the draft document at several national and
international meetings over an 18-month period and synthesis of
online comments of the draft document on the Papanicolaou
Society of Cytopathology website [www.papsociety.org]. This
document presents the results of these discussions regarding the
use of ancillary testing in the cytological diagnosis of biliary
and pancreatic lesions. This document summarizes the current
state of the art for techniques in acquiring cytology specimens
from the biliary tree as well as solid and cystic lesions of the
pancreas. Diagn. Cytopathol. 2014;42:333–337. VC 2014 Wiley
Periodicals, Inc.
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The sampling of the pancreas and biliary system for diag-
nostic cytology has been a major development in the
diagnosis and management of patients with pancreas–bili-
ary diseases.1 The increasing use of cytology has been
made possible through the development of endoscopic
techniques that provide minimally invasive tissue acquisi-
tion. Endoscopic retrograde cholangiopancreatography
(ERCP) guided brush cytology of the bile duct was the
initial example of providing an important diagnosis of bil-
iary malignancy. Recently, the use of endoscopic ultra-
sound (EUS) guided fine-needle aspiration (FNA) has
provided a supplemental technique for acquiring cytology
from the pancreas and the bile duct. Through continued
refinement in needles and tissue management, the diag-
nostic rates of FNA have improved dramatically. EUS-
FNA is now the procedure of choice for securing a
diagnosis of a pancreas malignancy. The recent introduc-
tion of techniques for obtaining core tissue samples from
the pancreas will further improve the accuracy of diag-
nostic cytology.
Bile Ducts
Bile Duct Brushing
Aspiration of bile duct juice during ERCP is the simplest
method of obtaining a cytology specimen for the evalua-
tion of a biliary stricture. The technique retrieves only
exfoliative cells in bile and does not involve brushing.2
A simple catheter is placed into the bile duct and bile is
aspirated. However, the sensitivity for this technique has
been disappointing, ranging from 6 to 32% for detecting
biliary malignancy.2,3 Because of the better yield of
brush cytology, bile aspiration alone is rarely used to
provide diagnostic cytology specimens. However, this
technique can be applied to specimens collected through
a chronic biliary drainage catheter.4 Cytologic analysis of
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bile duct tissue provides a more accurate diagnosis than
histologic processing of tissue.5 One study suggested that
the sensitivity could be improved by dilating the stricture
before bile acquisition, but significant complications have
been reported.6,7 Repeated brushings will improve the
diagnostic yield of biliary cytology.8 Retrieved biliary
stents can also be used as a source of cytologic material,
but brush cytology provides a better yield of cytologic
tissue.9
ERCP guided brush techniques. Biliary brush cytology
is the traditional method for collecting tissue from the
bile duct in the setting of a stricture.10 Standard cytology
brushes are guided through a stricture, over a wire, and
deployed across the stricture. The brush scrapes against
the biliary mucosa and retrieves cellular material from the
superficial mucosa. The brush is then retracted into a
sheath and the entire device is removed from the endo-
scope. Cytology material is retrieved from the brush by
smearing the cellular material onto a glass slide or into a
fixative solution.11
Recently, a newly designed cytology brush has been
introduced. The brush is 3 mm in diameter, 5 cm long, with
stiffer bristles than a standard cytology brush. The bristles
are oriented at 45 degrees on a 7 F sheath. By contrast, the
standard brush is 1.5 cm long and has bristles oriented at 90
degrees on a 6 F sheath. In a study comparing each type of
brush, all patients underwent sampling with each of the
brushes. The cancer detection rate was not significantly dif-
ferent with the two brushes (27 vs. 30%).12
Technique for tissue management. Biliary cytological
material is retrieved from a brush that has been placed
through a concerning stricture(s). The brush may be heav-
ily laden with tissue, blood, and clot. Retrieval of diag-
nostic material from the brush should be done in the
procedure room by trained endoscopy personnel.
The first step in the technique is to carefully open the
brush outside of the sheath and expose the bristles and
adherent tissue. Typically, the brush is placed against a
glass slide and a smear of tissue is made repeatedly on
several slides. After the tissue has been smeared off the
brush, the brush is cut from the catheter and the brush is
placed into a plastic tube containing fixative. The brush is
agitated in order to dislodge additional tissue from the
brush. At the completion of tissue retrieval, the brush can
be removed or left within the sample tube. The slides and
the sample tube are sent to cytology where the sample
tube is spun to isolate the tissue for a thin prep.
Traditionally, biliary brush cytology specimens have
been used solely for cytological analysis. Recently, the
use of the brush cytology specimens has been expanded
by using molecular markers and DNA-based testing.
Although p53 and KRAS mutations are commonly seen in
biliary malignancy, brush cytology specimens have not
generally been used for mutation analysis.13 Biliary brush
specimens for assessment of p53 mutations will require
separate processing and dedicated immunostaining.14
Recently, there have been efforts to develop more
objective testing of biliary cytology using image-based
testing of DNA histograms for ploidy analysis.15 Digital
imaging analysis and fluorescence in situ hybridization
(FISH) were evaluated in a study of 233 consecutive
patients undergoing ERCP for a pancreatobiliary stricture.
The patients underwent standard cytology, DIA, and
FISH.16 The test performance was similar across groups.
Standard cytology had low sensitivity (4–20%) but 100%
specificity. In patients with negative cytology, FISH
increased sensitivity while preserving specificity. The sen-
sitivity and specificity of DIA was intermediate between
routine cytology and FISH. The use of cytologic material
for FISH analysis does not require alteration in specimen
acquisition, except for additional material on slides.
Endoscopic Forceps Biopsy of the Bile Duct
Endoscopic forceps biopsy during ERCP is often performed
in combination with brush cytology in order to improve the
sensitivity of tissue sampling.17 In this technique, a small
diameter forceps is placed through a widely patent ampulla
and fluoroscopically directed to the area of interest in the
bile duct. The biopsy specimens are processed as histologic
specimens. Biopsies are often used to supplement brush
cytology. One study suggested that the combination of the
techniques increased the sensitivity by 15 to 25% com-
pared with either method alone. In a recent prospective
study of 26 patients, the sensitivity, accuracy, and negative
predictive values were 5.9%, 38.5%, and 36% for standard
cytology brushings, 29.4%, 53.8%, and 42.8% for standard
forceps biopsies, and 76.5%, 84.6%, and 69.2% for mini-
forceps biopsies, respectively.18 When comparing the three
methods of sampling, mini-forceps biopsy provided signifi-
cantly better sensitivity and overall accuracy compared with
standard cytology brushing and standard forceps biopsy.18
Bile duct biopsy specimens can also be smeared onto glass
slides for on-site cytology analysis.19 Although malignant
cytology is highly specific for a bile duct malignancy, atypia
can be seen in benign inflammatory lesions.20
Endoscopic Fine-Needle Aspiration of the Bile Duct
Needle biopsy of biliary strictures and masses is per-
formed with a biliary catheter contained as aspiration nee-
dle that be placed into the target lesion under
fluoroscopic guidance.21 A combination of brush cytology
and endobiliary biopsy with endoscopic FNA was more
sensitive (73–77%) than either method alone in at least
three reports.22 One study suggested that combining stric-
ture dilation, cytology, and FNA substantially improved
the accuracy for diagnosis of malignant strictures caused
by gallbladder or pancreatic cancer compared with cytol-
ogy alone.23
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Endoscopic Cholangioscopy
Endoscopic cholangioscopy is often performed using a
dedicated, small diameter endoscope that is placed
through the instrument channel for a duodenoscope.
Prospective single-center case series using either
endoscope-based or catheter-based systems have shown
that cholangioscopic visualization with or without biopsy
had a sensitivity of 89–100% and a specificity of 79–96%
for detecting biliary malignancies.24 Dedicated mini-
forceps for cholangioscopy are very small in diameter
and expensive. The small diameter forceps specimens are
processed using histologic techniques.
In a recent prospective study of 26 patients who under-
went sampling of a bile duct lesion using brush, standard
forceps, and mini-forceps biopsy, the sensitivity, accu-
racy, and negative predictive values were 5.9%, 38.5%,
and 36% for standard cytology brushings, 29.4%, 53.8%,
and 42.8% for standard forceps biopsies, and 76.5%,
84.6%, and 69.2% for mini-forceps biopsies, respec-
tively.18 When comparing the three methods of sampling,
mini-forceps biopsy provided significantly better sensitiv-
ity and overall accuracy compared with standard cytology
brushing and standard forceps biopsy.18
EUS-guided FNA of bile duct masses. Linear EUS can
readily image the bile duct and associated masses from
the ampulla to the birfurcation. EUS FNA of the bile duct
is usually performed across the duodenum and into a
focal mass arising from the bile duct. In a study of 24
consecutive patients with proximal biliary strictures
(upper one-third of the bile duct) and previously nondiag-
nostic ERCP brush cytology, EUS visualized a mass in
23 (96%) patients.25 EUS-guided FNA demonstrated
malignancy in 17 of 24 (71%) of patients. The overall
sensitivity, specificity, positive predictive value, negative
predictive value, and accuracy of EUS-FNA were 77%,
100%, 100%, 29%, and 79%, respectively.
Similar results were obtained in a study 81 patients
with confirmed cholangiocarcinoma who underwent EUS.
EUS identified the tumor in 76 patients (94%), a rate
higher than what was seen with triphasic computed
tomography (30%), or magnetic resonance imaging
(42%).26 EUS-FNA was performed in 74 of the patients
(91%) and diagnosed cholangiocarcinoma in 54 patients
for a sensitivity of 73%.26 The sensitivity was higher for
distal lesions than for proximal lesions (81% vs. 59%).26
Pancreas
ERCP-Guided Brush Cytology of the Pancreatic
Duct
The yield of aspirated pancreatic juice for exfoliative
cytology is very low and rarely used.24 Sampling of the
main pancreatic duct can be performed with techniques
similar to those used with brush cytology of the bile duct.
A wire-guided brush is used to collect cytologic material
from within a strictured pancreatic duct. There are signifi-
cant risks of pancreatitis with ductal brushing that can be
reduced by placing a stent at the conclusion of the
ERCP.27 The tissue yield of brush cytology of pancreatic
duct can be improved by stricture dilation.28
EUS-Guided Fine-Needle Aspiration Sampling
Devices for EUS guided FNA. Linear endosonographic
instruments are required to target lesions for FNA.29 The
instrument must initially be passed through the oral phar-
ynx, esophagus, and when necessary into the stomach and
duodenum. Prior gastric surgery, such a bypass or Whip-
ple resection, will restrict the ability of the echoendo-
scope to image targets adjacent to the stomach and
duodenum.
The appropriate gauge EUS needle should be selected
for the procedure based on the vascularity of the target
lesion, the difficulty in accessing the lesion, and type of
tissue needed for a diagnosis. Highly vascular lesions of
the pancreas as well as uncinated lesions should be aspi-
rated with a 25-gauge needle. The diagnosis of adenocar-
cinoma is best made with aspiration cytology.
Simple aspiration needles (usually 22- or 25-gauge) are
used in the vast majority of targets and provide similar
cytologic yield.30 Smaller gauge needles are easier to use,
generally safer, and the tissue yield is higher for pancre-
atic adenocarcinoma.31 Because the needles pass through
the mucosa of the gastrointestinal tract, there is potential
for contamination with epithelial cells. A 25-gauge needle
is often used for FNA of lymph nodes and vascular
lesions such as suspected neuroendocrine tumors (NETs)
and metastases from renal cell carcinoma. Mucinous cysts
are aspirated with 22-gauge needles because of the high
viscosity of the cyst fluid from IPMNs.
Core biopsy and Trucut needles (19-gauge) are used
for lesions such as stromal cell tumors, NETs, tumors
with suboptimal cytology yield, and for pancreatic lesions
that are suspicious for autoimmune pancreatitis. Small
gauge core biopsy needles have recently been made avail-
able and often used when standard aspiration techniques
do not provide a diagnostic tissue. Core biopsy specimens
for autoimmune pancreatitis should be processed for his-
tology as well as for IgG4 immunostaining.
Methodology for EUS guided FNA. Under constant EUS
guidance, the needle, occluded by a stylet, is placed
across the gastric or duodenal wall into the target lesion.
One quick thrust perpendicular to the wall of the lesion is
used to enter solid lesions, rather than a slow continuous
motion. Once the needle has been accurately placed into
the mass lesion, the stylet is removed and suction is
applied to the needle. In highly vascular lesions, minimal
suction should be used. In order to maximize the yield
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from aspiration cytology, the needle is moved to and fro
within the mass lesion using a fanning technique.32 The
suction is then turned off, the needle removed and the
specimen is placed onto the slide for processing. Addi-
tional specimens are obtained with separate passes of the
needle. Cytologic interpretation of the cytology specimens
on slides aids the endoscopists in obtaining specimens.
The degree of vacuum suction determines the amount of
aspiration tissue. Excessive suction may cause specimens
to be contaminated with blood. Specimens heavily conta-
minated with blood may be discarded.
Smear specimens are produced on glass slides and
placed in fixative, often ethanol. Cytology specimens are
expressed onto slides and two smears are made. One slide
is air-dried and stained with a modified Diff-Quik prepa-
ration for rapid interpretation on-site if available. The
other slide is wet fixed and later stained with a modified
Papanicolaou stain. Material may be obtained for cell-
block preparation for later immunocytochemistry testing.
Core specimens of the pancreas are sent for histology
sectioning. Large gauge needles and core biopsy needles
provide a core tissue for histologic interpretation and tis-
sue staining. Cytology specimens can be obtained from
the core by rolling the cores across slides.
Whenever possible, rapid on site evaluation of cytology
should be used because it reduces the frequency of falsely
negative FNA, particularly in the evaluation of pancreatic
masses.33 In general, sufficient needle passes will be
made until diagnostic material has been secured. Without
on-site cytology, approximately, 7 passes of a pancreas
mass are needed to maximize the sensitivity.34 Lymph
nodes can be evaluated with fewer passes, but stromal
cell tumors may require 3–5 passes.34
False-positive and false-negative cytological diagnosis
rates of pancreatic masses by EUS-FNA are low and may
result from technical difficulties, sampling or interpreta-
tion errors. The false-positivity rate of EUS-FNA for a
pancreatic lesion is about 2% and results from specimen
contamination by an intervening mucosal malignancy or
misinterpretation.35 A study of 367 patients with solid
pancreatic lesions in whom EUS-FNA cytology results
were interpreted as positive or suspicious for malignancy,
only four cases showed chronic pancreatitis on surgical
pathology. Chronic pancreatitis is also the most common
benign pathology causing false-negative interpretation of
a pancreatic cancer.
FNA of pancreas cystic lesions. FNA of cystic lesion
involves very similar techniques as FNA of solid lesions.
For suspected mucinous cysts, a 22-gauge needle is used
because of the low viscosity of the fluid. Serous cystade-
nomas and cystic NETs should be aspirated with a
25-gauge needle in order to minimize the risk of bleed-
ing. The cyst fluid from serous cystadenomas is thin and
easily aspirated. Pseudocysts should be aspirated with a
22- or 19-gauge needle in order to evacuate the entire
lesion of fluid which may become contaminated with
FNA. In general, one passage of the needle should be
used to evaluate a cyst and high suction will aid in the
rapid emptying of the cyst. Mural nodules or adjacent
masses can be aspirated separately or during the cyst fluid
aspiration. At times, the nodule and mass are more appa-
rent after evacuation of the cyst. There are reports of
enhancement of the quality of cytology specimens by tra-
versing the lining and wall of the cyst with several passes
of the needle with the risk of pancreatitis and leakage.36
Aspirated cyst fluid should be carefully aliquoted for
cytology, tumor markers, and DNA testing. If the primary
concern is a malignancy, priority should be given to
cytology. If typing of the cyst is the major clinical con-
cern, then the fluid should sent for CEA and kRAS-
GNAS. Cyst fluid should be centrifuged before assaying
the fluid for CEA and DNA analysis.
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